Status:
COMPLETED
Measuring Cognitive Enhancement During Hyperbaric Oxygen Treatments
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Hyperbaric Oxygen Therapy
Eligibility:
All Genders
20-40 years
Phase:
NA
Brief Summary
The aim of the current study was to examine the effect of short-term HBOT (hyperbaric oxygen treatments) on a range of cognitive abilities. The current study examined whether there is a HBOT-related s...
Detailed Description
The aim of the current study was to examine the effect of short-term HBOT on a range of cognitive abilities. The current study examined whether there is a HBOT-related short-term cognitive improvement...
Eligibility Criteria
Inclusion
- Age 20-40
- intact sight / corrected sight
- Hebrew as mother tongue
- Intact comprehension
Exclusion
- Active neurologic or psychiatric diagnosis.
- If Had been treated with HBOT for any other reason prior to their inclusion;
- Chest pathology ;
- Inner ear disease;
- Claustrophobia;
Key Trial Info
Start Date :
November 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 2 2018
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT04358796
Start Date
November 10 2017
End Date
November 2 2018
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf Harofeh Medical Center
Ẕerifin, Israel